Path to regulatory approval - a new era? Discussion at Edison Open House: Global Healthcare 2021

OpGen - Edison Open House: Global Healthcare 2022Подробнее

OpGen - Edison Open House: Global Healthcare 2021Подробнее

InMed Pharmaceuticals at Edison Open House Global Healthcare Conference 2022Подробнее

2021 life sciences investment opportunities - discussion at Edison Open House Global Healthcare 2021Подробнее

Edison Open House Global Healthcare 2022: Open 100Подробнее

InMed's CEO Eric A. Adams presents at Edison Open House: Global Healthcare 2021Подробнее

Edison | Open House Global Healthcare 2022Подробнее

Instem - Edison Open House InterviewПодробнее

Global Healthcare Insights: Why U.S. Needs Change Now!Подробнее

The future of medicine: Can telehealth revolutionize global healthcare access? | A conversation w...Подробнее

Edison Open House Global Healthcare 2022: Panel Three - Trends and hot topics in biopharma partn...Подробнее

A new era in global health surveillance and strategy - Working together to build capacityПодробнее

A new era for global health – Professor Peter Piot in conversationПодробнее

Regulatory aspects of Personalised Healthcare - GlobalПодробнее

Edison Open House Global Healthcare 2022: Panel Two - Distinguishing 2022's healthcare innovatio...Подробнее